Literature DB >> 28592441

FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma.

Ning Lyu1, Youen Lin2, Yanan Kong3, Zhenfeng Zhang1, Longzhong Liu1, Lie Zheng1, Luwen Mu1, Jianpeng Wang4, Xishan Li5, Tao Pan1, Qiankun Xie1, Yaru Liu1, Aihua Lin6, Peihong Wu1, Ming Zhao1.   

Abstract

Entities:  

Keywords:  Advanced HCC; FOLFOX; HAIC

Mesh：

Substances：

Year:  2017        PMID： 28592441     DOI： 10.1136/gutjnl-2017-314138

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  15 in total

Review 1.  Hepatic Arterial Infusion Chemotherapy Is a Feasible Treatment Option for Hepatocellular Carcinoma: A New Update.

Authors:  Maher Hendi; Yiping Mou; Jiemin Lv; Bin Zhang; Xiujun Cai
Journal:  Gastrointest Tumors       Date:  2021-07-15

Review 2.  Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models.

Authors:  Qilong Wang; Ping Zhang; Zhongmin Li; Xiangru Feng; Chengyue Lv; Huaiyu Zhang; Haihua Xiao; Jianxun Ding; Xuesi Chen
Journal:  Theranostics       Date:  2019-02-20       Impact factor: 11.556

3.  Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin.

Authors:  Yang Zhao; MinKe He; RunBin Liang; QiJiong Li; Ming Shi
Journal:  Ther Clin Risk Manag       Date:  2021-01-22       Impact factor: 2.423

4.  Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma.

Authors:  Jie Mei; Yu-Hao Tang; Wei Wei; Ming Shi; Lie Zheng; Shao-Hua Li; Rong-Ping Guo
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

5.  Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma.

Authors:  Jie Mei; Shao-Hua Li; Qi-Jiong Li; Xu-Qi Sun; Liang-He Lu; Wen-Ping Lin; Lie Zheng; Min-Shan Chen; Ming Shi; Wei Wei; Rong-Ping Guo
Journal:  J Hepatocell Carcinoma       Date:  2021-03-25

6.  Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy.

Authors:  Chao An; Mengxuan Zuo; Wang Li; Qifeng Chen; Peihong Wu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

7.  Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma - 2020 Guangzhou Recommendations.

Authors:  Qi-Feng Chen; Wang Li; Simon Chun-Ho Yu; Yi-Hong Chou; Hyunchul Rhim; Xiaoming Yang; Lujun Shen; Annan Dong; Tao Huang; Jinhua Huang; Fujun Zhang; Weijun Fan; Ming Zhao; Yangkui Gu; Zhimei Huang; Mengxuan Zuo; Bo Zhai; Yueyong Xiao; Ming Kuang; Jiaping Li; Jianjun Han; Wei Song; Jie Ma; Peihong Wu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

8.  Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy.

Authors:  Shousheng Liu; Jinfa Lai; Ning Lyu; Qiankun Xie; Huijiao Cao; Dabiao Chen; Meng He; Bei Zhang; Ming Zhao
Journal:  Front Oncol       Date:  2021-02-01       Impact factor: 6.244

9.  Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy.

Authors:  Zhiqiang Wu; Wenbo Guo; Song Chen; Wenquan Zhuang
Journal:  Invest New Drugs       Date:  2020-10-01       Impact factor: 3.850

10.  Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma.

Authors:  Run-Bin Liang; Yang Zhao; Min-Ke He; Dong-Sheng Wen; Xiao-Yun Bu; Ye-Xing Huang; Zhi-Cheng Lai; Yu-Jie Xu; Anna Kan; Wei Wei; Yao-Jun Zhang; Min-Shan Chen; Rong-Ping Guo; Qi-Jiong Li; Ming Shi
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.